VEGFA and colorectal carcinoma: Furthermore, although PGF was not significantly increased in blood cells from CRC patients, it was also analyzed because of its role promoting angiogenesis, in resistance to antiangiogenic therapy and as an alternative pro-angiogenic ligand to VEGF-A in the VEGF pathway.